Emily Pimblett

CIK: 0001969365

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (50.0%)

Position reduction

Option Exercises (M)4 (40.0%)

Derivative conversions

Awards (A)1 (10.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLYM

Climb Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

CLYM
Climb Bio, Inc.
Jun 20, 2025
Sale(S)
Direct
1.2K shares at avg. $1.24$2K
CLYM
Climb Bio, Inc.
Jun 18, 2025
Exercise(M)
Direct
5K shares-
CLYM
Climb Bio, Inc.
Mar 20, 2025
Sale(S)
Direct
1.2K shares at avg. $1.31$2K
CLYM
Climb Bio, Inc.
Mar 18, 2025
Exercise(M)
Direct
5K shares-
CLYM
Climb Bio, Inc.
Jan 13, 2025
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
CLYM
Climb Bio, Inc.
Dec 19, 2024
Sale(S)
Direct
1.2K shares at avg. $2.02$2K
CLYM
Climb Bio, Inc.
Dec 18, 2024
Exercise(M)
Direct
5K shares-
ELYM
Eliem Therapeutics, Inc.
Sep 20, 2024
Sale(S)
Direct
9 shares at avg. $8.06$72.54
ELYM
Eliem Therapeutics, Inc.
Sep 20, 2024
Sale(S)
Direct
1.2K shares at avg. $8.18$10K
ELYM
Eliem Therapeutics, Inc.
Sep 18, 2024
Exercise(M)
Direct
5K shares-

		Type	Shares	Price		Ownership
Jun 20, 2025	CLYM Climb Bio, Inc.	Sale(S)	1,242	$1.24	$1,540	Direct
Jun 18, 2025	CLYM Climb Bio, Inc.	Exercise(M)	5,000	-	-	Direct
Mar 20, 2025	CLYM Climb Bio, Inc.	Sale(S)	1,199	$1.31	$1,571	Direct
Mar 18, 2025	CLYM Climb Bio, Inc.	Exercise(M)	5,000	-	-	Direct
Jan 13, 2025	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Dec 19, 2024	CLYM Climb Bio, Inc.	Sale(S)	1,235	$2.02	$2,495	Direct
Dec 18, 2024	CLYM Climb Bio, Inc.	Exercise(M)	5,000	-	$0	Direct
Sep 20, 2024	ELYM Eliem Therapeutics, Inc.	Sale(S)	9	$8.06	$73	Direct
Sep 20, 2024	ELYM Eliem Therapeutics, Inc.	Sale(S)	1,182	$8.18	$9,669	Direct
Sep 18, 2024	ELYM Eliem Therapeutics, Inc.	Exercise(M)	5,000	-	$0	Direct

1-10 of 10 transactions

About Pimblett Emily

Pimblett Emily (SEC CIK 0001969365) files insider reports with the SEC as SVP, Finance and CAO of Climb Bio, Inc. (CLYM).

Signal8 holds 5 ownership filings by Pimblett Emily, all Form 4s, filed between Sep 20, 2024 and Jun 20, 2025. Those filings report 10 transactions, from Sep 18, 2024 to Jun 20, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Pimblett Emily's filings is in WELLESLEY HILLS, MA.

Recent filings by Pimblett Emily

Jun 20, 2025: Open-market sale of CLYM shares (Form 4, code S).
Jun 18, 2025: Option exercise of CLYM shares (Form 4, code M).
Mar 20, 2025: Open-market sale of CLYM shares (Form 4, code S).
Mar 18, 2025: Option exercise of CLYM shares (Form 4, code M).
Jan 13, 2025: Grant or award of CLYM derivative securities (Form 4, code A).

Other insiders filing for Climb Bio, Inc. (CLYM)

How to read Form 4 transaction codes